Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-18

Clinical Trial Update: Xerostomia in Patients With a Life-limiting Condition or Frailty [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating xerostomia (dry mouth) in patients with a life-limiting condition or frailty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Xerostomia, Dry Mouth | Phase 3 | Status: UNKNOWN